title: Angiotensin-Converting Enzyme Inhibitors-Beneficial Effects Seen in Many Patient Groups May Not Extend to Kidney Transplant Recipients.
authors.affiliation: 1 Department of Nephrology, Canterbury District Health Board, Christchurch, New Zealand. 2 Department of Medicine, Otago University, Christchurch, New Zealand. 3 Sydney School of Public Health, University of Sydney, NSW, Australia. 4 Centre for Transplant Renal Research, Westmead Hospital, Westmead, NSW, Australia.
authors.forename: Nicholas B
authors.initials: NB
authors.lastname: Cross
authors.forename: Angela C
authors.initials: AC
authors.lastname: Webster
mesh_terms: D047228:Angiotensin II Type 1 Receptor Blockers / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D019317:Evidence-Based Medicine; D006801:Humans; D006973:Hypertension / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D016030:Kidney Transplantation / Q000009:adverse effects*; D018579:Patient Selection; D011507:Proteinuria / Q000209:etiology; D016032:Randomized Controlled Trials as Topic; D051436:Renal Insufficiency, Chronic / Q000150:complications / Q000175:diagnosis / Q000601:surgery*; D016896:Treatment Outcome
chemical_list: D047228:Angiotensin II Type 1 Receptor Blockers; D000806:Angiotensin-Converting Enzyme Inhibitors; D002121:Calcium Channel Blockers